コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 that retained full coverage (P<0.001 for the adjusted analysis).
2 sits variation) of the untreated fellow eye (adjusted analysis).
3 [CI], 5.2-40.8;P= .0109, using a propensity-adjusted analysis).
4 o, 1.48; 95% confidence interval, 1.03-2.13; adjusted analysis).
5 lihood of hyperphosphatemia in multivariable-adjusted analysis.
6 pared with higher levels of each variable in adjusted analysis.
7 sians or Hispanics compared with NHWs in the adjusted analysis.
8 9, 95% CI 1.50-6.37, overall P=0.007) in the adjusted analysis.
9 and race-adjusted analysis to 0.89 in fully adjusted analysis.
10 ations between GB and CPQ11-14 scores in the adjusted analysis.
11 found to be associated with infection in the adjusted analysis.
12 (34.4%; P=.04) by the prespecified covariate-adjusted analysis.
13 nd 0.74 (0.46-1.20) for the propensity score-adjusted analysis.
14 ted only with higher risk of ESRD in a fully adjusted analysis.
15 , but the association was not significant in adjusted analysis.
16 cant comorbid conditions through matched and adjusted analysis.
17 and WRF on outcome was not significant in an adjusted analysis.
18 postoperative pressure ulcer development on adjusted analysis.
19 re TBI (HR 5 11.4, 95% CI 5 7.4-17.5) in age-adjusted analysis.
20 were tested using multivariate time-to-event adjusted analysis.
21 d odds of nvAMD in unadjusted and confounder-adjusted analysis.
22 CI, 1.03-1.74; P = 0.02) in propensity score-adjusted analysis.
23 ly associated with cancer mortality in fully adjusted analysis.
24 ) in East Europe compared to South Europe in adjusted analysis.
27 stimate was attenuated and nonsignificant in adjusted analysis (adjusted hazard ratio = 0.77, 95% con
28 ype seemed to be associated with worse OS on adjusted analysis (adjusted hazard ratio = 1.57; 95% CI,
29 gh this was not statistically significant in adjusted analysis (adjusted HR, 0.36; 95% CI, 0.05 to 2.
34 dence interval], 8.7 [2.0-37.3]; P=0.004 for adjusted analysis and 3.4 [0.8-13.8]; P=0.07 for the una
36 requency repeated measures did not differ in adjusted analysis between groups post baseline (mean dif
43 I, 1.14-1.28) than were white patients in an adjusted analysis, but there were no significant racial
44 to the current practice of prospective risk-adjusted analysis by a National Surgical Quality Improve
50 >/=15 mm in thickness and in those with LGE; adjusted analysis demonstrated that segmental presence o
57 ociated with higher in-hospital mortality in adjusted analysis (GFR, 60-89; odds ratio [OR], 1.5; 95%
58 tality was observed for the entire cohort on adjusted analysis (hazard ratio, 0.99; 95% CI, 0.94-1.04
59 associated with cardiovascular events in an adjusted analysis (hazard ratio, 1.08; 95% confidence in
60 ot associated with risk for heart failure in adjusted analysis (hazard ratios, 1.0 [reference], 0.77
66 nterval [CI] 0.62 to 0.87; p < 0.001) and in adjusted analysis (HR 0.80, 95% CI 0.66 to 0.97; p = 0.0
68 1 to 0.95; p < 0.001) and multivariable risk-adjusted analysis (HR per unit change for mortality risk
69 or trend < 0.01) but not in the multivariate-adjusted analysis (HR: 1.09; 95% CI: 0.98, 1.21; P for t
70 y associated with type 2 diabetes in the age-adjusted analysis (HR: 1.91; 95% CI: 1.72, 2.11; P for t
72 rmore, the pattern of variation changed: the adjusted analysis identified three new outliers, and two
73 or of outcome for the composite end point in adjusted analysis III (hazard ratio=0.808; 95% CI, 0.689
75 her systolic blood pressure was confirmed in adjusted analysis in the Chicago Genetics of Hypertensio
76 ve implantation devices were observed at the adjusted analysis in Valve Academic Research Consortium
87 vorable neurocognitive outcome in propensity-adjusted analysis (odds ratio, 1.61; 95% confidence inte
90 (95% CI, 0.26-0.84; P = .01) for a covariate-adjusted analysis of propensity-matched data to 0.61 (95
97 gnificantly associated with ASD in partially adjusted analysis (OR, 1.20; 95% CI, 1.06-1.36), but thi
101 rtality based failure to rescue in the fully adjusted analysis (P<0.05); however, the extended stay b
105 d properly, then the resulting ascertainment-adjusted analysis produces parameter estimates that gene
107 and 1.06 (95% CI, 0.93 to 1.22) in the fully adjusted analysis restricted to women with depression.
108 be correctly modeled, then an ascertainment-adjusted analysis returns population-based parameter est
112 and nonischemic cardiomyopathy groups after adjusted analysis (RR 0.99, 95% CI 0.86 to 1.15; p = 0.9
113 not present in those taking pravastatin (age-adjusted analysis: RR, 0.98; 95% CI, 0.47-2.04; P =.046
123 2.29), and in the maximally (multivariate-) adjusted analysis the relative risk was 1.59 (95% CI: 1.
137 education changed from 0.79 in age- and race-adjusted analysis to 0.89 in fully adjusted analysis.
140 associated with incident T2D in multivariate-adjusted analysis until body mass index was adjusted: od
148 5-0.82, P < 0.001) had lesser Star scores on adjusted analysis, whereas patients with a cancer diagno
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。